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A review is given of current, mostly biochemical, research on 
the muscarinic and the nicotinic acetylcholine receptors. The review 
contains 74 references. 
Acetylcholine receptors (AChR) as operational entities have been described 
for a great many years. They have been localized by iontophoretic application 
of acetylchoHne (ACh) or by binding of ligands. It appeared obvious that 
they were part of the postsynaptic membrane and their protein nature was 
early suggested by Nachmansohn. Drug structure-activity studies revealed se-
veral kinds of acetylcholine receptors probably requiring different ACh 
configuration. With the introduction of biospecific chromatography ACh 
binding molecules could be isolated from postsynaptic membranes of mammalian 
brain and peripheral tissue and from the electric tissue of certain fishes . Their 
chemical and physical properties are currently studied. Experiments on mem-
brane reconstitution using isolated AChR are in progress in a number of 
laboratories, aiming at a clarification of the question if the isolated ACh 
binding proteins also are responsible for ion translocation or not. While this 
still is an open question and may turn out to be different in muscarinic and 
nicotinic systems, isolation of AChR has shown that this molecule differs 
from that of the ACh hydrolyzing enzyme acetylcholinesterase (AChE). 
This review summarizes some of the current biochemical research on the 
muscarinic (mAChR) and the nicotinic (nAChR) acetylcholine receptor. Some 
other interesting aspects of current receptor research, such as receptor loca-
lization and the nature of the extrajunctional ACh-sensitive sites found after 
denervation are also touched upon. 
MUSCARINIC ACETYLCHOLINE RECEPTOR 
Estimates ,of mAChR levels in brain and peripheral tissue have been 
made by Rang1, Burgen2 and others using either tritiated atr.opine or atropine-
-like compounds such as 3-quinuclidinyl benzilate (3-QNB) or tritiated choline 
mustard derivatives. 
Atropine has a low lipid solubility while that of 3-QNB and related 
compounds is high as is their anticholinergic activity both in the CNS and 
396 E . HEILBRONN 
in the peripheral nervous system3 ,4• Oxotremorine (100 µM) maximally dis-
places [3H]-QNB binding5• As shown in the following 3-QNB binding mAChR 
is postsynaptically located. Binding of [3H]-QNB to rat hippocampus was 
measured after septal lesions which reduced choEne acetyltransferase (CAT) 
activity 65-760/o in hippocampal homogenates. Specific binding of [3H]-QNB 
was hardly altered. Even AChE was reduced by about 700/o which confirmed 
earlier observations6,7 of an almost ex clusively presynaptic location in the 
hippocampus. 3-QNB binding, however, is postsynaptic. Presynaptic mAChR 
sites may have different binding properties and not be labelled with 3-QNB 
or else presynaptic sites, which have been described in the cerebral corrtex8 
and are supposed to be involved in ACh-release do not exist in hippocampus. 
Hippocampus develops no supersensitivity to iontophoretically administered 
carbamylcholine following septal lesions or to 3-QNB-binding9• Binding of 
[ 3H]-QNB reaches half-maximal rate of association at 2-3 min and a plateau 
value in about 10 min. Half maximal binding occurs at about 0.1-0.2 nM 
3-QNB and plateaus at about 1 nM. Lesioned and control animals are about 
equal. Dissociation is slow, ti;, for the 3-QNB receptor complex at 35 °c 1being 
about 60 min in both control or lesioned rats. Nonspecific binding is not time 
dependent and not saturable. 
Choline mustard derivatives are potent alkylating muscarinic antagonists 
as shown in smooth muscle and brain and their binding to mAChR is anta-
gonized by a variety of reversible agonists and antagonists, including ACh. 
Scatchard plots obtained for gui·nea pig ileum ·suggest the presence of two 
binding sites for ACh with affinities of 1.8 X 10s M-1 and 1.6 X 106 l\·P in about 
equal amounts. The total receptor concentration found by ACh inhibition is 
identical with that found with atropine2• 
The purification of mAChR is a tricky business. Solubilization studies in 
our laboratories indicate that mAChR is less firmly bound to its membrane 
than nAChR. The. protein, once it is removed from the membrane, is rather 
unstable. Tritiated benzilylcholine mustard ([3H]-BCM) has been used in some 
purification experiments. After fractionation the highest specific ligand binding 
activity was found in the microsomal fraction, together with AChE and 
5'nucleofadase. Density and differential centrifugation have been used. Attempts 
to solubilize mAChR with detergents resulted in a protein unable to bind 
[3H]-BCM. On SDS gel solubilized protein-marker complexes were found to 
have apparent Mol. wt. of 23 000 and 30 000. Altogether 12-15 bands were 
present. 
In our laboratories, mAChR is currently purified in collaboration with 
T. Bartfai1° and others. While preparirng a biospecific adsorbent, we have 
used conventional methods for a partial purification (Fig. 1). By routine, 
mAChR is followed with tritiated atropine. Binding equiHbrium at 4 °C is 
only slowly reached, in about 48 hrs. Solubilized receptor looses its ability 
to bind acetylcholine or atropine rather quickly. Even in a homogenate, 900/o 
of the atropine binding capacity is lost within a week. 
Atropine binding is blocked by muscarine but not by tubocurarine or 
eserine. ACh binding was studied in the presence of anticholinesterases, as so 
CHOLINERGIC RECEPTORS 
PARTIAL PURI FICATION OF mAChR FROM RAT BRA IN 
Procedure 
Homogenate in 10 % sucros e 
11000xg,30 ' , 2x 
"' 
i 
Supe rnatant (S 1 l t lO OOOxg , 40 ' 
Nuclear pellet (P 1} 
I 
Crude mitochondria 1 
pe llet (CMP} 
l M NaCll 
12 hr 
CMP in 0 .1 M NaCl 
100 OOOxg l 
120 ' -





2 M NaCl l 
12 hr 
P3 in 2 M NaCl---? (alternati vely detergents) 





Dialysi s , concentrat ion , ge lfiltrati on 
Spec. activity atropine 







Fig. 1. Steps in partial purification of the muscarinic ACh .. receptor from rat brain (unpublished). 
far 0.1-0.50/o of original acetylcholinesterase activity are found in the receptor 
preparation. On gelelectrophoresis 3 bands are seen, 2 of which are also present 
in the esterase. The third band corresponds to mAChR. Gelfiltration of this 
material gives ·apparent Mol. wt. of 33 000 and 68 000. mAChR .thus seems to 
be a much smaller functional unit than nAChR. This •should perhaps be seen 
in relation to studies indicating that mAChR might act through guanyl •cycfa.se. 
Possibly we are here dealing with a regulatory unit. In the preparations guanyl 
cyclase follows atropine binding in :all steps of subcellular fractionation. 
It is known that ACh causes accumulation of cGMP in heart, brain and 
intestinal tissue and ACh as well as muscarinic agonists cause an increase in 
cGMP levels in rabbit cerebral cortical slices, an action that rs abolished by 
atropine but not by the nicotinic agonrst hexamethonium. Nicotinic agonists do, 
in this system, not affect cGMP levels. The physiological response to mAChR 
activation may thus be mediated by cGMP which in its turn would be com-
patible with the slowly developing nature of the responses resulting from 
activation of mAChR on cerebral neurones. Iontophoretically applied cGMP 
itself is, however, -not acting like ACh on neurones (cat cerebral cortex). It 
excites cells that are depressed by ACh as well as those which are unaffected 
by ACh11 • 
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NICOTINIC ACETYLCHOLINE RECEPTOR 
So far the most successful studies of AChR1:r17 at the molecular level have 
been done on electric tissue from either Electrophorus electricus, Torpedo 
marmorata or californica. Some information is also available on nAChR from 
mammalian tissue. 
There may be heterogenioity in nAChR, as indicated e.g. by studies on 
denervated muscle and on purified nAChR. Denervation of the skeletal 
muscles causes a spread of ACh-sensitive regio'l11S18 over the whole muscle fibre 
membrane. The increase in ACh sensitivity is a:bout 20 times, a value that 
has been confirmed by studying binding of radioactive cholinergic ligands, 
particularly ACh antagonists1sa,tD,20. 
The chemical nature of the apparently newly formed receptors may not 
be altogether identical with that of the normal receptors found at neuro-
muscular junctions. In normal muscle the receptors are almost exclusively 
confined to the region of the muscle surface underlying the nerve termirual21 •22. 
After denervation, the receptors spread though the peak receptor concentration 
in the extrajuncttl.onal membrane never reaches that of the end plate mem-
brane23·24. Junotional receptors in denervated muscle resemble those from 
normal muscle though Berg and Hall25 showed that binding of a[125I] -
-bungarotoxin to extrajunctional receptors in organ cultures of denervated 
(5 days) rat diaphragm muscle is more rapidly reversilble than that to 
junctional receptors of normal muscle. Endplate regions were avoided when 
testing the denervated muscle. Inhiibitors of energy production, such as NaCN 
or dinitrophenol and of pwtein synthesis, such as cycloheximide at a con-
centration blocking 95°/o of protein ·synthesi:s block the rapid loss of the 
toxin. This finding may reflect a rapid turnover of the toxin-receptor complex 
in the membrane. Extrajunctional regions of denervate.d muscle also have a 
more rapid recovery of ACh sensitivity after a-<bungarntoxin blockade as com-
pared to reoovery of the end plate regions of normal muscle26. This may not 
to be due to a difference in dissociation constants, but rather to an active 
metabolic process, probably linked to pwtein synthesis. The toxin seems to 
be degraded as radioactivity is found in the medium as iodotyrosin. An intra-
cellular, energy requiring process27 might be acting and reflect normal receptor 
turnover in the membrane. 
Even normal skeletal muscle nAChR shows heterogenity. Using [125I]a-
-bungaroto:icin (a-<bgt) and autoradiography and incubating until no response 
to nerve stimulation was noticed28, Fertuck and Salpeter showed that AChR 
is localized in the postsynaptic membrane nearest the primary cleft (i.e. ·nearest 
the axon) and not throughout junctional folds. This is in contrast to AChE label-
led with [3H]-DFP where the radioactiv.ity is distributed over a broad band 
coinciding with the junctional fold region29 • Using electron microscope auto-
radi.ography of a-[3H]-bgt binding sites Albuquerque30 estimated the mean 
density of nAChR in various skeletal muscles to 8 700 per µm 2 even though 
the overall size of an endplate ranged from 400 µm2 to 1 300 ·µm 2• Highest 
amounts are found nearest the axon and are about 18 000 a -bgt sites. Only 
half of them appear to be true active centers of AChR i.e. have h!i.gh affinity 
for d-tubocurarine and lose all response to ACh upon treatment with a-bgt. 
The other half is thought likely to be on the ion conductance modulator 
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component of the receptor system.31,32 There are few binding sites in the folds 
compared to the ti:p and ACh sensitivity seems to be determined by the local 
density of receptors in the membrane and not by their total number at the 
endplates. Freeze-etched preparations show 100-140 A particles, presumed 
to include receptor-ionic conductance modulator complexes33. 
The area of the postsynaptic membrane may be adapted to the number 
of quanta needed for synaptic function. The zone of effectiveness of one 
quantum (10 µM at 1 µm radius from the odgin in 0.3 ms) is 3 µm2 of post-
synaptic membrane34. 6 000 single channels should be open for the generation 
of one miniature endplate current. 700/o of the surviving part >Of 10-20 000 ACh 
molecules is, according to Katz and Miledi, receptor bound, which does not 
saturate the available receptor sites (,.., 30 000 true functional centres). Yet 
only about 250/o of the entire number of functional receptor centers can be 
removed without diminishing the response to neurally-released ACh35. This 
leads to one, or at the most two, ACh-activated receptor sites per available 
ion channel. 
In cultured skeletal muscle cells clusters of AChR are formed in rthe 
absence of neurons and participate probably in synapse formation36• AChR 
might function as determinant of synapse recognition. The average AChR 
concentration is 9 000 receptors/µm 2 and the receptors resemble those found 
in electroplax. At other regions the receptor concentration is 900/µm 2• Clusters 
of AChR on cultured muscle cells were also demonstmted with ferri1tin-a~bgt 
conjugates37, and peaks of sensitivity are also found using focal iontophoresis 
of ACh38• Lt seems not yet known if receptors in cultures are. heterogenous or 
not. 
In the electroplax, the number of toxin binding sites iper square micron 
of cell surface in subsynaptic or extrasynaptic areas was estimated with 
Naja nigricollis a-neurotoxin38a. Denervation by destruction of the caudal rpart 
of the spinal cord of Electrophorus electricus electric organ does not change the 
number of a-neurotoxi:n sensitive sites significantly up to 142 days after 
denervation38b, but remains 10-20 nmol/g protein. In the normal electroplax 
no clusters of toxin binding sites are seen except under the nerve endings. 
These latter binding sites remain even after denervation, though no residual 
nerve processes are seen. Thus, in the electroplax the ratio of extrasynaptic 
to subsynaptic a-neurotoxin binding sites does not change for several weeks 
after denervation. No new receptor sites are appearing. 
Using a-hgt the number of receptor sites per g, tissue in Torpedo electric 
tissue was estimated39 to be 6.6 X 1014. Mouse, rat and frogmuscle endplate have 
respectively 1.6 X 107, 4.7 X 107, and 1 X 109 sites per endplate40. The number 
of sites is again considerably larger than the number of ACh molecules released 
by a single nerve impulse (about 3 X 106 in rat diaphragm) indicating many 
spare receptors41 or other sites. 
Several review articles12-17 have recently summarized information avail-
able about purified nAChR. Therefore the following is rather condensed. 
Karlin et al. 42 have shown that ACh-receptors of electroplaques can be blocked 
by reagents which reduce S-S bonds to S-H groups and be restored by 
oxidizing agents. Karlin has purifued receptor subunits after affinity labelling 
(Table I) . Another appr.oach was used by Miledi et al. 43 who purified 
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a receptor-a-toxin complex. Others: (Table II) have used bio:specific chromato-
graphy. nAChR is a membrane pimtein, which has to be .solubilized W1ith neutral 
detergents. Affinity chromatography (Table II) has been performed on flaxedil 
or choline derivatives15,43a,44 or on acetylated45 or native :a-'neurotoxin from Naja 
naja siamensis46- 4s,55 or from Naja naja naja49 bound to a matrix. The isolated 
acid protein mateirial was shown to bind to Concanavalin A and some :other 
lectins15, indicating that it is a glyco1protein. Its main sugars are mannose, 
glucose and galactose47 (Table III). N-acetylglucose amine is also present. Tests 
for sialic acid have been negative. The a:mino acid composition of nAChR has 
been determined and is different from that of AChE15,4s,59, Some differences 
seem to exist between nAChR from Torpedo or Electrophorus. Some Tor-
pedo data are summarized in Table IV. 
TABLE I. 






Apparent Mol wt. 
I 
Ref. 
T. marmorata 1 3~4 1 45 000, 50 000 I 
45 





28 000, 35 000, 42 000 
I 
44 
3 40 000, 50 000, 65 000 64 
E. electricus 1 
I 
40 000 
3 32 000, 40 000, 103 000 42 
2 
I 
43 000, 48 000 51 
1 ? 48 
T A BLE II . 
Columns used in affinity chromatography of nicotinic ACh-receptor 
Tissue Active part of affinity column Ref. 
T . marmorata a-toxin Naja naja siam. 46, 47, 56 
ac. a-toxin 45 
T . californica -NH(CH2)5CONH(CH2)sW(CHa)3 44 
E. electricus a -toxin N aja naja naja 49 
a-toxin siam. 48 




Sugars found in purified nicotinic ACh-receptor•1 
Total carbohydrate: 38 ± 18 1.•g per mg nAChR. 
Amount of sugar (O/o) 
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Summary of data obtained on nAChR from Torpedo marmorata16,• 5- •1,59 
Membrane bound macromolecule, solubilized by neutral detergents 
Glycoprotein or glycoproteolipid; mannose, galactose, glucose, glucosamine 
Isoelectric point 4.8 
Binds ACh, Hill coeff 1 below 10-G M 
Amino acid polarity - 49, tryptophan, half-cystin 
Properties change upon storage 
EM size 80-100 A, pit about 15 A, 5-6 subunits (?) 
Separable into two proteins : 
Mapp: 295 000 ± 30 000; 410 000 ± 40 000 (n = 9); proportion (1.6 ± 0.2) : 1 
Both bind acetyl a-neurotox,in, K0 resp. 6 X 10-s M and 8 X 10-7 M 
3- (4) subunits in SDS, Mapp 42 000, 51 000, 74 000 and (92 000) 
Acetylation gives subunits of about 95 000 
Maleylation gives peptides of about 32 amino acids 
Antigenic 
The isolated glyooprotein appears as ·one15 or as two interacting1" ,45 macro-
molecules. Molecular weights are approximative, as detergents a•re usually 
bound to the protein. The shape of the protein may be elongated rather than 
globular50• In our laboratory two a-neuro1toxin binding macromolecules have 
been separated and it was recently show n that their binding properties differ. 
Their amino acid composition seems, however, to be close to identical, wh:ile 
the number of their subunits may differ. None orf the two proteins contains 
any AChE activity at all. It remains to be seen if the pr.oteins are. different 
parts of a bLi.nding site - ion trans1ocation unit or different oligomers of the 
same subunits. 
Treatment with SDS in the presence of dithiothreitol results in 1-5 
subunits (Table I) depending upon methods and source of electric organ. 
Subunits are in the range between 25 000 and 70 000. The smallest toxin 
binding unit is 90 000-140 000 (Table V) . 
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TABLE V. 
Size of toxin (1 mol) binding site of purified nAChR 
g Ref. 
T . marrnorata [3H] ac a-toxin 140 000 46 
Naja naja 
T . californica [125!]-a-Bgt 100 000 64 
E. electrophorus calc. 
[3H] pyr. a-toxin 90 000- 48 
Naja naja 180 000 
[ 3H] a.-toxin 150 000 15 
Naja naja 
Binding of ligands is influenced by the ,nature and amount of detergent 
present16. It seems therefore meaningless to compare binding data obtained in 
different laboratories. Upon solubilization nAChR changes its affinity for 
agonists, while that of antagonists remaiins approximately as in the membrane51 . 
ACh binding is blocked by nicotinic antagonists. 
The existence of an nAChR heterogenicity, observed by us, may, however, 
also be indicated by the. different ACh-ibinding constants found in the literature, 
though, as also mentioned above, these may be influenced by detergents and 
by methods used. Moody et al.52 , using equilibrium dialysis on purified pre-
paration from T . californica found a single dissooiaUon constant Ko = 2.3 µM, 
Elfman and Heilbronn (unpubl. data) found 1 ~tM using equilibrium dialysis 
on purified T. marmorata nAChR, Weber and Changeux53 using displacement 
of radioactive N aja toxin from a particulate preparation of T. marmorata 
found K0 = 8 nM. Some studies on T. marmorata using equiHbrium dialysis 
give Scatchard plots indicating two binding constants of 7 nM and 0.07 µM 
respectively in a particular preparation5\ 1.4 nM and 0.22 µM in a Lubrol 
solubilized preparation55 and 20 nM and 1.97 µM in a highly purified preparat-
ion56. O'Brien and Gibson57 found that nAChR puriifued from stored T . mar-
morata electroplax preparations gives Scatchard plots indicating two ACh 
binding sites and showed that the high affinity site was heat-labile. The 
particulate AChR preparations however, are heat-stable. The two ACh sites 
also have different pH-profiles but both have a typical nicotinic drug profile. 
Assuming simple competitive binding it was shown that several nicotinic drugs 
blocked high affinity ACh-binding better than low affinity ACh-binding. This 
may coincide with our observationss,59 that the two isolated AChR macro-
molecules have different affinities for n -neurotoxin. There is also the observat-
ion that car.bamylcholine releases only about 50°/o of nAChR from an 
a-ne.urntoxin-Sepharose column after incubation for 12 hrs at room tem-
perature. It was assumed that this was due to a secondary reaction between 
nAChR and a-neurotoxin. A secondary reaction has been described by Klett 
et al.48 • The amount of irreversibly bound receptor can be reduced considerably 
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by a shorter incubation time, which seems to underline the explanation given 
above. Such .preparations always yield two nAChR macromolecules, as described 
earlier in this paper. When discussing binding sites of ipurified nAChR the 
possibility that residues of ligands used in affinity columns are bound to the 
isolated material has also to be kept in mind. This can be checked with 
immunological methods. 
Identification of the isolated material is achieved by binding studies using 
agonists and antagonists. Further, antibodies to nAChR have been raised in 
rabbits45,49,ao-s2 and these are shown to be able to precipitate nAChR from a 
solution and to crossreact with nAChR. The antibodies do not react with AChE 
or with a-neurotoxin used for the purification nor do antiibodies to those 
compounds react with nAChR. Antibodies to nAChR are able to block the 
response of electroplax to carbamylcholine or that of the dorsal muscle of 
the leech to ACh. The important question if the isolated glycoprotein is the 
ACh recognition site only or includes the ion translocation mechanism has not 
yet been answered. In the electron microscope rosettes .of nAChR are seen, 
having a size of about 80-100 A and a pit of - 15 A (ref. 15, 16). These 
rosettes are destroyed16 by SDS and may represent the nAChR macromolecule 
with an inner part .alliowing ion passage. Structures resembling those of the 
isolated material are seen in the electroplax membrane after freeze-etching63 . 
Currently, synthetic lipid vesicles containing AChR (freed from detergent via 
cholate) are studied64 • In the presence of carbachol and cholinergic .blockers 
such as the a-neurotoxins these vesicles ·behave as the microsacs, sealed 
electroplax membrane vesicles which may be loaded wri.th 22Na+. This cation 
is extruded in the presence of an ACh agonist, .an effect that is blocked by 
a-neurotoxin or by d-tubocurarine. It is suggested that the synthetic vesicles 
cantain everything necessary for neurotransmitter recognition and ion trans-
location. 
Experiments with AChR in black lipid membranes have shown conduc-
tance changes as a function of added choliner.gic agonists65- 67• According to 
Michaelson et al.64 nAChR contains a neumtransmitter site and a second 
binding subsite which complexes inorganic cations and bisquaternary cholinergic 
analogues. 
It is .obvious that the lipid surroundings of nAChR in the membrane 
are of importance in receptor function . Using chromatography on LH-20 and 
chloroform-methanol De Robertis68 and collaborators have isolated a proteolipid 
from the electroplax and shown that it had properties of a nicotinic cholinergic 
receptor and bound ACh. These studies have been criticized because of the 
utilization of organic solvents in the extraction procedures, which might be 
expected to denature proteins on the basis of information available from 
conventional globular proteins. It is possible, however, that the organic solvents 
still contain sufficient residual water molecules to permit unusual hydrophobic 
proteins to remain in solution. A recent study by Levinson et al.69 has challenged 
the procedures used since it was found that chloroform-methanol treatment 
eliminates the binding activity of whole micr.osomes (electroplax) and does not 
solubilize the receptor in active form . It was also claimed that peaks from the 
LH-20 column capable of ACh binding could be created in the presence of 
protein-free and receptor-free extract. It was suggested that the binding is 
nonspecific and that the receptor-ligand intera<:tion may be artifactual. Fiszer 
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de Plazas and De Robertis70 have compared their material with detergent-
-solubilized material and shown a-bgt binding, KD 4.9 X 10-1 M (1 mol per 
37 000 Mol. wt. equiv.). They also showed that the toxin was not replaced by 
ACh or decamethonium and that, although the toxin could not be extracted 
into the organic phase the binding activity was lost from the protein residue 
and appeared in the extract. The quantity of the extracted material resembles 
that of .others (3-7 X 104 mol g-1 tissue). 
We have recently repeated the procedures described by De Rohertis et aL 
In one experiment T . marmorata electroplax was used. In the other one the 
receptor was labelled with [3H]-acetyl a -neurotoxin before chromatography. 
Two protein peaks were obtained on the LH-20 Sephadex column, extracted 
with chloroform. Addition of methanol did not elute further material. The 
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Fig. 2. Elution pattern for neurotoxin-labelled protein or proteolip id from a LH-20 Sephadex 
column. - protein, .. .. radioactivity. 
to react the nonlabelled isolated p11oteins with a-neurotoxin nor did these 
protein fractions react with antibodies to nAChR prepared in our laboratory 
from immunized rabbits. Cross immunoelectrophoresis was attempted after 
removal of organic solvents by low temperature evaporation and all proteins 
were tested after addition of either buffer or buffer containing 10/o Triton 
X-100. The conclusion from this seems to be that proteins prepared by LH-20 
chromatography with chloroform-methanol may be denatured and that they 
cannot react with either acetyl a-neurotoxin or with antibodies to nAChR 
prepared :by the use of detergents, not directly and not after treatment with 
detergent to break up a possible proteolipid. 
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Within the frame of this article it has not been possible to review all 
information available from recent studies on membrane bound or solubilized 
cholinergic receptors. Mainly biochemical data have been sought out. Other 
articles from this meeting bring out more information or discuss other aspects. 
A survey of present knowledge, however, makes it obvious that rapid deve-
lopment is to be expected particularly concerning functional aspects of mus-
carinic and nicotinic receptors. The mechanism of muscarinic cholinergic trans-
mission may tum out to be rather different from that of nicotinic cholinergic 
transmission. It is also obvious that the last h as n ot yet been said about the 
nature of the isolated nicotinic acetylcholine receptor glycoprotein(s). 
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DISCUSSION 
E. A. Barnard: 
With regard to the heterogeneity of neuroto~in binding seen in one of your 
experiments, is it possible that this arises from the presence of more than one 
isomer in the acetylated toxin separation that was used? In the case of a -bungaro-
toxin, we have observed that different isomeric mono-acetyl-derivatives can be 
separated, which differ somewhat in their affinity between each other (and w e u sed 
only one of those, which has unchanged affinity). If a mixture of mono-acetylated 
toxiin species was present, its behaviour could differ, perhaps, from one form of the 
receptor to the other. Has this been ex cluded? 
E. Heilbronn: 
According to dr. Karlsson who prepares the acetylated toxin, the acetyl-group 
is on the N-terminal (isoleucin). Neurotoxins labelled in Lys 23 or Lys 49 have also 
been used. The affinity of these three derivatives for nAChR in labelling experiment 
was shown by Libelius to be the same. 
M. E. Eldefrawi: 
(a) Did I hear you correctly saying that your purified receptor solution is con-
taminated with bacteria? (b) The results of your ACh binding show 20 nmol/mg 
protein at saturation, yet your toxin binding saturates below 5 nmol. How do you 
reconcile the difference between the two numbers? 
E. Heilbronn: 
(a) When we observed the presence of two AChR oligomers we decided to 
culture a sample in order to see if any bacteria at all were present. In this sample 
1 000 bacteria/ml were found. After this discovery we have been using sodium azide 
and sterile filtering, with little difference in the isolated proteins. (b) The v alues 
you are comparing were not measured on the same AChR sample. However, while 
toxin binding at saturation does not vary much from sample to sample, ACh-binding 
at saturation does vary considerably, in fact by as much as up to a factor of 10. 
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SAZETAK 
Najnovija istrazivanja s podrucja kolinergiCnih recept.ora 
Edith Heilbronn 
Nacinjen je pregled najnovijih, pretezito biokemijskih, istrazivanja s podrucja 
muskari.nskih i nikotinskih receptora acetilkolina. Prikazom je obuhvaceno 74 re-
ferenci. 
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